very day, millions of people undergo surgical procedures facilitated by anesthesia. 1 Recognition that physicians need to take individual variability into account is driving huge interest in personalized or "precision" medicine. 2 Yet, in the field of anesthesiology, we have no accepted method or monitor to measure anesthetic susceptibility of a person in a quantitative fashion. Our work describes one possible method to start this process, the use of functional imaging of the auditory cortex to quantify the effects of anesthesia.
The effect of sedation and anesthesia on brain function using brain-mapping methods has been the topic of investigation for many years. The primary goal of this line of research in anesthesiology has been to support theories about the effects of sedative-hypnotic and analgesic drugs on the central nervous system (CNS). We previously examined the interaction of sedation and pain perception using both psychophysical methods 3 and magnetic resonance imaging (MRI) based approaches. 4 Our previous work using 5 O-water positron emission tomography 6 supports an emerging theory that propofol, when given at anesthetic doses, acts by inhibiting the thalamo-cortical signal transmission. This hypothesis was recently substantiated in a study using functional connectivity analysis 7 for propofol. However, there is little or no information on the effects of other sedative hypnotic drugs on the functional MRI signal of any cortical region.
The thalamo-cortical axis is a key portion of central nervous integration of the 5 senses: somatosensation, vision, hearing, smell and taste. Hence, a quantitative assessment of this effect is a logical target for study. Because blood oxygen level-dependent functional MRI (BOLD fMRI) has been shown to be particularly reliable with respect to visual and auditory stimuli, we chose to study the effect of sedation on the auditory cortex. We have studied the global effects of propofol before, 6 but the effects of this and other sedative hypnotic drugs on cortical processing is unclear. This issue is particularly relevant to studies in primates and small children that cannot be performed without sedation. We now present a novel approach to quantify the effects of several sedative hypnotic drugs, thus providing a possible solution to some of the challenges of measuring subtle effects of anesthetic drugs in an objective fashion.
In this prospective randomized study, the effects of 3 sedative drugs given at comparable doses and a no-drug (control) group were examined with respect to auditory brain activation. The primary objectives of this study were to determine whether mild intravenous sedation changes the magnitude or extent of auditory cortex activation (mean signal amplitude in the auditory cortex) and whether any observed effects would differ by drug type. We compared our drug intervention with a no-drug (control) group, although it is generally assumed that neither task repetition nor mild sedation affects BOLD fMRI. An exploratory study aim was to determine whether BACKGROUND: Every day, millions of people undergo surgical procedures facilitated by anesthesia. Yet, there is no clinically accepted measure to predict the effects of sedation or anesthesia on the central nervous system. Auditory brain activation may provide an objective and quantifiable method to measure of the effects of sedation on neuronal processing. METHODS: This is a randomized clinical trial. Forty-eight healthy volunteers were randomly assigned to receive 1 of 3 sedative drugs (midazolam [n = 11], propofol [n = 12], or dexmedetomidine [n = 12]) at a concentration adjusted to achieve mild sedation by self-rating, or to a no-drug control group (n = 13). Participants underwent functional magnetic resonance imaging while listening to music in a 5-minute block design experiment. We tested the hypothesis that mild sedation changes the magnitude or extent of cortical activation of an auditory stimulus. RESULTS: We observed a significant reduction in auditory activation in both the dexmedetomidine (P = .001) and midazolam (P = .029) but not the propofol group (P = .619) when compared with saline control. CONCLUSIONS: Our findings indicate that, compared with saline control, there is a significant reduction of brain activation in the auditory cortex in response to midazolam and dexmedetomidine but not propofol when given at mildly sedative doses. This method serves as a novel approach to quantify the effects of sedative agents in an objective fashion. (Anesth Analg 2017;124:1603-10)
METHODS

Subjects and Design
The IRB of the University of Alabama at Birmingham (Birmingham, AL) approved this study. Between November 2010 and March 2015, subjects were recruited by use of public advertisements placed around the university campus. Interested individuals underwent a screening visit during which we determined eligibility by obtaining a medical history, performed a focused physical examination, and obtained written informed consent. Inclusion criteria were healthy adults between 19 and 40 years of age, who were able to understand all study instructions. Exclusion criteria were any existing and active medical conditions that could affect somatosensation or cognitive function such as diabetes mellitus, neurologic diseases, chronic pain, psychiatric disorders, treatment with any controlled substance, or a history of drug or substance abuse. The data for this report are a subset of an ongoing study with a focus on somatosensory processing where auditory processing is used as a control task.
Subjects were randomly assigned to 1 of 3 sedative treatments (midazolam, propofol, dexmedetomidine) on the day before the study. Random assignment of subjects receiving sedation was determined by a list created with the PLAN procedure in SAS, version 9.4 software (SAS Institute, Cary, NC) and was balanced to blocks of 5 participants. One participant was excluded on the day of the study because of the presence of a previously undisclosed drug in the medical history. No intravenous access was established in the no-drug (control) group.
As part of the first study session, an individual's dose for moderate sedation was determined, as described in the Administration of Intravenous Sedation section. The auditory fMRI was performed on a separate day during which the previously established sedative dose was used.
Administration of Intravenous Sedation
A 20-Ga intravenous catheter was placed on the left forearm. Drugs were infused with a Graseby 3400 infusion pump (Smiths Medical, St. Paul, MN) controlled by a personal computer using the Stanpump software (available at www. opentci.org 8 ). This software uses a 3-compartment pharmacokinetic model adjusted by height, weight, age, and sex to predict plasma concentrations of intravenous drugs. This computer-assisted infusion was approved by the US Food and Drug Administration (IDE #G060183) for research use. Pharmacokinetics for propofol were published by Marsh et al, 9 and pharmacokinetic parameters for the administration of dexmedetomidine and midazolam were published by Dyck et al 10 and Greenblatt et al, 11 respectively. Unlike traditional drug infusions, the infusion rate varies constantly to rapidly attain and maintain a desired drug plasma concentration with this method. The method has great utility in a situation where the investigator needs to rapidly achieve a drug plasma concentration, as in this study.
Dose Finding Procedure
On a separate day of the MRI study visit, the dose of medication for mild sedation was determined. The goal of this procedure was to establish a comparable level of sedation for all participants receiving intravenous sedation regardless of drug assignment. The dose required to achieve moderate sedation was based on the person's individual sedation rating, a sedation biomarker that has been shown to correlate well with intravenous drug concentrations and observer assessment of sedation. 12, 13 Subjects received escalating doses of their assigned intravenous sedative. They were asked to rate their own sedation after having received 10 minutes of intravenous sedation at each level by making a mark on a 10-cm horizontal line bounded by "fully awake" to "completely sedated" (sedation self-assessment scale). Doses were increased in predefined steps (see below) every 10 minutes until participants were considered moderately sedated by making their sedation mark at the midsection of the sedation self-assessment line (at 5 cm on a 10-cm sedation selfassessment scale) or within the right half of the sedation line (between 5 cm and 10 cm of the sedation self-assessment scale). Drug dose steps were based on previously published data [9] [10] [11] 13 for "effect site" concentrations. For dexmedetomidine, we used effect site concentrations of 0.1, 0.2, 0.4, 0.6, and 0.8 ng/mL; for midazolam, we used effect site concentrations of 10, 20, 40, 60, and 80 ng/mL; and for propofol, we used effect site concentrations of 0.4, 0.8, 1.2, and 1.6 μg/mL. Because the dose finding was incremental (in fixed steps) in the number of steps, time of the dose finding procedure, and cumulative drug dose to achieve moderate sedation varied. We recorded both the effect site concentration at which moderate sedate was obtained and the cumulative drug dose in milligrams used for any given participant.
The effect site concentration for a particular participant was recorded and used for the MRI session during which sedation was initiated after the baseline MRI and continued for 20 minutes before the repeated MRI session was performed.
Subject Monitoring
All subjects were monitored according to the standards of the American Society of Anesthesiologists using pulse oximetry, electrocardiogram, and noninvasive blood pressure in addition to inspection of subject's breathing and circulation.
Statistical Analysis
Statistical analysis was performed using the Statistical Analysis System version 9.4 (SAS Institute, Cary, NC). We focused our analysis on changes of the auditory cortex, which have been shown to be particularly sensitive to the processing of music.
14 The statistical analysis of cluster size was done on temporally realigned but otherwise untransformed (no other preprocessing steps) images. The analysis on signal magnitude within the auditory cortex (superior temporal gyrus) was done on realigned and spatially normalized images to match the coordinate space of the auditory cortex mask.
We examined differences of treatment groups with an analysis of variance (ANOVA) on difference scores (sedation minus baseline values) for both signal magnitude within the region of interest (ROI) and cluster size resulting in 2 independent ANOVA models. We inspected the histogram of residual errors of the 2 ANOVA models for gross deviation from normality. Post hoc analyses of pairwise group differences were done with the Dunnett test. As a point of reference, we compared the distribution of the difference scores in the saline control group to a hypothesized mean of zero using a signed rank test.
We performed 2 independent multivariable analyses to investigate our exploratory study aim of investigating race and sex effects. These analyses were done with a mixed model with drug, time (baseline versus sedation | repeated), race, and sex as fixed effects; subject as random effects; and either mean signal amplitude or cluster size as outcomes in separate models. In these analyses, we considered race and sex predictors of interest and drug and time control variables. This approach allowed us to quantify the overall temporal change in mean auditory activation or cluster size and to evaluate the effect of predictors such as race and sex while controlling for other explanatory variables in the model. We did not include interaction effects of race and sex or race and drug because the number of subjects in the subcategories defined by these interactions would have been too small to produce stable prediction parameters.
Sample Size Calculation
Our power analysis was performed using G*power (Department for Psychology, Heinrich Heine University, Düsseldorf, Germany).
15 P values < .05 were considered statistically significant. The primary outcome for this study was the change in the size of the auditory activation cluster. Activation of the primary and secondary auditory cortex would consist of approximately 1500±750 voxels at a 2-mm isometric voxel size. The sample size to detect a 33% reduction in the activation cluster using a within-subject correlation of 0.7 to obtain 80% power was n = 10 per group. Since exact comparative data on the expected temporal change of auditory activation do not exist, we based our assumptions about the expected magnitude of CNS effects because sedations were based on our previous experiments on saccadic eye movements. 16 Imaging Design and Analysis a. Acquisition and Data Format: MRI images were acquired on a Siemens Allegra 3T brain scanner using the Siemens imaging software version syngo MR 4VA25A (Siemens Healthcare NV, Beersel, Belgium). We recorded functional and 1 structural (anatomical) image. We note that structural images were not required for the target frequency analysis (TFA) but obtained as reference. Functional runs consisted of a series of 150 echo planar images using the following scanning parameters: a repetition time of 2000 ms, an echo time of 30 ms, and a flip angle of 70°. We obtained 30 slices of 4-mm thickness with 4 mm by 4 mm pixel spacing. The acquisition matrix was 64 by 64 elements resulting in a 254 mm by 254 mm fieldof-view. Two images (equilibration scans) preceded the run of 150 images; they were generated but not recorded. The structural image was a T1-weighted magnetization-prepared rapid acquisition gradient echo sequence using a 12° flip angle. We obtained Realigned functional runs were used to perform the TFA (see point c below). Further preprocessing of realigned images was only performed for the purpose of illustrating group activation maps ( Figure 2 ) and conducted as follows: manual normalization of each individual's TFA image to match the "single subject T1" template provided with Statistical Parametric Mapping (SPM) using the "Display" and "Check Registration" options in SPM using a manual 9-degree-of-freedom linear affine transformation. Individual steps of this process were resetting the brain's origin to the anterior commissure (translations along x, y, and z), 3-axis rotations (pitch, roll, and yaw), and scaling along x, y, and z. c. TFA: Details of the theoretical framework of this analysis are provided in Frölich et al. 5 The analysis involves the following steps: loading the 4D Neuroimaging Informatics Technology Initiative images into a 4-dimensional matrix (dimensions: 64×64×30×150); normalizing the time series by subtracting the mean and dividing by the standard deviation along the time dimension for each brain voxel using matrix commands; and extracting the target frequency component from the BOLD fMRI intensity time series using the Goertzel algorithma single command step in MATLAB-and calculating the frequency amplitude (absolute value) of each brain voxel. TFA images were thresholded to a value of 23.22, the 95th percentile of a Nakagami (1,150) distribution after spatial normalization (see above) to generate activation maps. We measured both the mean auditory TFA amplitude and the size (number of voxels) of the auditory cluster. For this analysis, we normalized individual activation maps as described in point d below and selected the superior temporal gyrus bilaterally as ROI using the MARINA (MAsks for Region of INterest Analysis, Version 0.6.1, Bertram Walter Bender Institute of Neuroimaging, University of Giessen, Giessen, Germany) system. 17 We used the average amplitude of all voxels included in the ROI as outcome measure for this analysis. d. Cortical Rendering (Figure 2 ): We illustrate our findings in Figure 2 . To create this figure, several transformations were needed. Individual TFA amplitude images were spatially normalized (see point b above) and thresholded (see point c above). Normalized images were then smoothed using a 8×8×8 Gaussian smoothing kernel. A drug group average of spatially normalized TFA amplitude images was created using the "imcalc" command of SPM. Cortical rendering to a smoothed normalized surface was done 
Auditory Stimulation
The auditory stimulation consisted of 8 seconds royalty-free music clips representing a variety of music genres that were stored as motion picture expert group type 4 files and played through an fMRI-compatible headset to study subjects during their functional scan. This design and the associated analysis outlined below are illustrated in Figure 1 .
RESULTS
Descriptive Statistics and Demographics
There were n = 12 participants in the propofol, n = 12 in the dexmedetomidine, n = 11 patients in the midazolam group, and n = 13 patients in the no-drug (control) group. Race, age, body mass index, or sex distributions did not appear different across drug groups. Final effect site concentrations and cumulative drug doses are summarized in Table 2 .
Auditory Activation Change
The residual errors of both ANOVA models (difference in cluster size and difference in mean activation within the auditory cortex) appeared approximately normally distributed. We observed a significant difference in drug groups with respect to change in mean auditory activation (F df = 3,44 = 6.059, P = .002; see Figure 3A ). Changes in mean auditory activation, comparing active drugs to saline control, are listed in Table 3 . We note that, in the post hoc analysis, both dexmedetomidine and midazolam but not propofol differed significantly from saline control. As a point of reference, auditory activation did not change significantly in the saline control group (P = .636). We did not observe a significant treatment group differences with respect to change in auditory cluster size (F df = 3,44 = 0.400, P = .753; see Figure 3B ). Changes in cluster size, comparing active drugs with saline control, are listed in Table 4 . The mixed model with cluster size as outcome showed a significant time effect (P < .001) indicating that, after adjusting for other independent variables in the model, cluster size decreased significantly. Race was also a significant predictor in this model (P = .041). This effect can be appreciated better by reporting the least square means (LSM) and standard errors (SE, in parentheses) for cluster size, which are as follows: in African Americans, the LSM was 1237 (197) voxels; in the "other" category, the LSM was 1020 (347) voxels; and in the Caucasian race category, the LSM was 1745 (128) voxels. In this model with cluster size as outcome, neither drug (P = .395) nor sex (P = .596) were significant predictors. The lack of the drug effect is consistent with the findings of the ANOVA model (see Statistical Analysis section). In the mixed model with mean auditory signal amplitude as outcome, only time was a significant predictor (P < .001) after controlling for other predictors in the model. Neither race, drug, nor sex were significant predictors in the latter model.
DISCUSSION
This study utilized a novel approach to quantify the effects of mild sedation to address 2 important scientific questions: whether there is a drug effect of mild sedation on auditory brain activation and whether any observed effect is specific to a particular drug. As supplemental analysis, we evaluate whether there are any race and sex effects in auditory processing while controlling for drug.
The use of the extent of cortical neuronal activity and the signal magnitude as a quantitative measure of sedative susceptibility is an innovative approach to evaluating the effects of mild sedation. These effects are too subtle to be observed in a reproducible and quantifiable fashion by current objective evaluation measures. The quantitative analysis we describe is based on the straightforward TFA approach that determines the agreement of the observed periodic signal from a block-design fMRI experiment with an a priori defined periodic stimulus. This approach is very useful because, unlike the most commonly applied general linear model analysis approach, the method does not require exact knowledge about the dynamics of the perceived stimulus. In other words, it does not matter whether the stimulus perception increases, decreases, or is delayed over the stimulation block. Similarly, it does not matter whether these responses vary across brain areas as long as the response remains of periodic nature. Because existing methods, mostly based on processed electroencephalography data, have proven unsatisfactory as objective biomarkers for the effects of mild sedation, we utilized the change in auditory fMRI activation, a well-validated outcome in the imaging community, in the new context of quantifying the effects of sedation. In the following discussion, we will review the existing MRI and electroencephalography literature on the effect of sedative anesthetic drugs on functional imaging measures, followed by an interpretation of our specific findings.
A drug-specific effect would support that the different pharmacology of sedative drugs, γ-aminobutyric acid (GABA) acting versus α-2-receptor acting, translates into a characteristic action at a functional level as opposed to adopting the hypothesis that sedative hypnotic drugs invoke a uniform response at a functional level. Although the effect of general anesthesia with propofol on brain activation has been studied before, 6, 19 this study is the first to test the effects of 3 different intravenous sedative drugs on the cortical response to an auditory stimulus when administered in the anxiolytic, mildly sedative range. We observed an overall reduction in the magnitude and extent of the auditory activation at doses titrated to achieve the same biological effect, which was determined by the subject's sedation self-report.
Although there was no evidence to suggest that the magnitude of auditory activation decreased, we observed a reduction in the size of the activation cluster in the saline group similar to the change seen in the sedation groups. This effect may reflect some level of habituation to the repeated administration of a stimulus. Another noteworthy detail is that, compared with saline control, the magnitude of auditory activation decreased significantly in both midazolam and dexmedetomidine but not in the propofol group, suggesting that perhaps propofol has a lesser effect on auditory CNS processing compared with midazolam or dexmedetomidine. Our finding of a similar reduction of cluster size in the saline group compared with the sedation groups suggests that the extent of cortical activation of auditory fMRI is very sensitive to repeated test administration and overall reduced when participants receive an intravenous sedation even at a very small (anxiolytic) dose. Our observation that auditory fMRI results change with repeated task administration independently confirms existing electrophysiologic work 20 and has important implications for neuroimaging experiments in general. MRI acquisition sequences are presented in sequence to accommodate various image www.anesthesia-analgesia.org
ANESTHESIA & ANALGESIA modalities and may occasionally be quite lengthy, for example, 20 minutes, by themselves. At times, subjects need to be sedated to reduce anxiety or simply to tolerate the fMRI procedure, as in the case of studying children 21 or when studying animals. 22 Experimenters usually assume that small doses of sedation do not affect functional imaging results and that imaging results are not affected by task repetition. Our study finding of a cluster size reduction in the saline group should serve as caution for investigators employing long and repeated imaging sequence while assuming no habituation effect.
The most promising finding of our study is that we were able to document reproducible effects of sedation at very low doses, which has not been possible with other techniques such as auditory-evoked potentials (AEPs). The concept of AEP has been used to assess anesthetic depth. 23, 24 Auditory latency has been described as an effective index for the effects of general anesthetics, [25] [26] [27] although these anesthetic effects are only notable at doses used to maintain full anesthesia 28 or higher sedation doses. 29 One of the key differences in AEP and auditory fMRI is that AEP monitor brainstem responses. In humans, sound information from the inner ear travels down the vestibulocochlear nerve, through intermediate stations such as the cochlear nuclei and superior olivary complex of the brainstem and the inferior colliculus of the midbrain, being further processed at each relay station. The information eventually reaches the thalamus, and from there, it is relayed to the cortex. [30] [31] [32] Evoked potentials are thought to reflect activity in these brainstem structures. In contrast, auditory fMRI measures the extent to which the auditory cortex is activated by a sound stimulus. In the human brain, the primary auditory cortex is located in the temporal lobe. It is subdivided into a primary (AI), secondary (AII), and further association areas. 33 As such, the neuroanatomical targets of AEP and auditory fMRI as implemented in our study differ, and this difference may account for the difference in sensitivity of the technique to sedative-anesthetic effects whereby AEPs are only affected by sedative doses that are higher than the ones used in our study.
A secondary finding was that non-Hispanic Caucasian study subjects showed a significantly larger area of auditory brain activation when compared with the African American and other race categories, after controlling for sex and treatment. Although this observation needs to be interpreted with caution because of the small sample size, person-specific anesthetic susceptibility has been observed in a different context. 34 The challenge in quantifying anesthetic effects has been that to date, there is no reliable biomarker that is considered a reliable test to evaluate person-specific responses to anesthetic medications in an objective fashion. Sedation self-rating as used in our study has been shown to perform well when compared with other methods, 35 but it is a subjective assessment. There are other validated methods of quantifying anesthetic susceptibility such as the evaluation of the speed of saccadic eye movements 16 or neurocognitive evaluation tools. 36 These types of evaluations may be important for individuals considered at risk for suffering untoward effects from exposure to sedation and anesthesia 37 ; they are impractical for clinical use based on the time required to complete them. In this regard, a 5-minute auditory fMRI study as used in our study may provide a more practical and an objective measure of the sensitivity to sedative-hypnotic drugs.
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